3-N-BUTYLPHTHALIDE
Neuroprotection
Hui-Sheng ChenSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Neuroprotection cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Recombinant Human Plasminogen Activator Capital Medical University | Phase 2 | B |
Tenecteplase Capital Medical University | Phase 2 | B |
Darbepoetin Alfa University of Pennsylvania | Phase 2 | B |
Oxygen Capital Medical University | Phase 2 | B |
Tirofiban Capital Medical University | Phase 2 | B |
Same molecule, other indications
3-N-BUTYLPHTHALIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →